We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Assays With Pediatric Settings

By HospiMedica staff writers
Posted on 16 Jan 2006
New clinical chemistry assays have pediatric settings designed to enable clinicians to obtain a full-result profile the first time, without having to prioritize because of the small size of the sample.

The new pediatric settings are available from the diagnostics division of Olympus Life and Material Science Europa GmbH (Hamburg, Germany) and they have received the CE Mark. More...
The settings are available for the complete range of Olympus analyzers: the AU400, AU600/AU640, and AU2700/AU5400.

The range of settings includes 22 analytes: albumin, ALP (2), ALT, AST, bicarbonate, bilirubin direct, bilirubin total, calcium (2), creatinine, C3, C4, GGT, glucose, IgM, iron, LDH (2), transferrin, triglyceride, and urea.

The new settings also reduce sampling that can be unnecessary or stressful in newborns or children. The problem of being able to obtain only a small sample is not confined to pediatric patients. The increasing number of geriatric patients in the healthcare system presents similar problems, such as shrunken or broken veins. Chemotherapy patients may have large numbers of puncture sites.

"We therefore see there being wide potential for using these low-volume settings by customers and thus both increasing test profiling capabilities and reducing patient distress,” said Dr. Christoph Mauracher, of Olympus.

The Diagnostics Division of Olympus provides in vitro diagnostic products for clinical chemistry, electrophoresis, and pre-transfusion testing.




Related Links:
Olympus Life and Material Science Europa GmbH

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.